Banka Bioloo [BANKA] vs Secmark Consultancy [SECMARK] Detailed Stock Comparison
Banka Bioloo
NSE
Loading...
Secmark Consultancy
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Banka Bioloo wins in 8 metrics, Secmark Consultancy wins in 10 metrics, with 0 ties. Secmark Consultancy appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Banka Bioloo | Secmark Consultancy | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.14 | 43.52 | Secmark Consultancy |
| Price-to-Book Ratio | 3.00 | 6.85 | Banka Bioloo |
| Debt-to-Equity Ratio | 109.95 | 31.97 | Secmark Consultancy |
| PEG Ratio | -0.57 | -0.06 | Banka Bioloo |
| EV/EBITDA | -30.61 | 33.75 | Banka Bioloo |
| Profit Margin (TTM) | -17.55% | 9.01% | Secmark Consultancy |
| Operating Margin (TTM) | -2.66% | -21.18% | Banka Bioloo |
| Return on Equity | -28.21% | 20.93% | Secmark Consultancy |
| Return on Assets (TTM) | -10.84% | 12.69% | Secmark Consultancy |
| Free Cash Flow (TTM) | $-36.13M | $93.63M | Secmark Consultancy |
| 1-Year Return | -30.97% | 42.92% | Secmark Consultancy |
| Price-to-Sales Ratio (TTM) | 1.82 | 3.98 | Banka Bioloo |
| Enterprise Value | $1.25B | $1.30B | Secmark Consultancy |
| EV/Revenue Ratio | 2.38 | 3.61 | Banka Bioloo |
| Gross Profit Margin (TTM) | 76.15% | 64.21% | Banka Bioloo |
| Revenue per Share (TTM) | $50 | $35 | Banka Bioloo |
| Earnings per Share (Diluted) | $-8.48 | $3.10 | Secmark Consultancy |
| Beta (Stock Volatility) | 0.54 | -0.19 | Secmark Consultancy |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Banka Bioloo vs Secmark Consultancy Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Banka Bioloo | -3.63% | -3.27% | -1.69% | 22.00% | -10.89% | -15.12% |
| Secmark Consultancy | 2.40% | 0.00% | -4.22% | -19.68% | 46.51% | 15.59% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Banka Bioloo | -30.97% | 20.04% | 94.09% | 85.02% | 85.02% | 85.02% |
| Secmark Consultancy | 42.92% | 40.60% | 40.60% | 40.60% | 40.60% | 40.60% |
News Based Sentiment: Banka Bioloo vs Secmark Consultancy
Banka Bioloo
News based Sentiment: NEGATIVE
Banka Bioloo faces significant financial challenges, as evidenced by four consecutive quarters of negative results and a high debt-to-EBITDA ratio. While there's been some short-term stock performance improvement and leadership continuity, the overall narrative is one of caution due to ongoing struggles and increased regulatory scrutiny.
Secmark Consultancy
News based Sentiment: NEGATIVE
The significant decline in profitability metrics during Q1 FY 2025-26, despite a year-over-year revenue increase, is a major concern for investors. While the company is proceeding with standard corporate actions like the AGM and ESOP allotments, the negative financial performance overshadows these positive developments, making this a noteworthy month for the investment story.
Performance & Financial Health Analysis: Banka Bioloo vs Secmark Consultancy
| Metric | BANKA | SECMARK |
|---|---|---|
| Market Information | ||
| Market Cap | ₹951.14M | ₹1.43B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 11,461 | 1,821 |
| 90 Day Avg. Volume | 21,277 | 2,033 |
| Last Close | ₹82.02 | ₹132.10 |
| 52 Week Range | ₹56.99 - ₹140.00 | ₹75.00 - ₹174.63 |
| % from 52W High | -41.41% | -24.35% |
| All-Time High | ₹166.80 (Jan 29, 2024) | ₹174.63 (May 19, 2025) |
| % from All-Time High | -50.83% | -24.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | 0.14% |
| Quarterly Earnings Growth | -0.99% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.18% | 0.09% |
| Operating Margin (TTM) | -0.03% | -0.21% |
| Return on Equity (TTM) | -0.28% | 0.21% |
| Debt to Equity (MRQ) | 109.95 | 31.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹29.26 | ₹19.71 |
| Cash per Share (MRQ) | ₹4.32 | ₹15.94 |
| Operating Cash Flow (TTM) | ₹-34,863,000 | ₹35.11M |
| Levered Free Cash Flow (TTM) | ₹-89,087,000 | ₹42.94M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Banka Bioloo vs Secmark Consultancy
| Metric | BANKA | SECMARK |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.14 | 43.52 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.57 | -0.06 |
| Price to Sales (TTM) | 1.82 | 3.98 |
| Price to Book (MRQ) | 3.00 | 6.85 |
| Market Capitalization | ||
| Market Capitalization | ₹951.14M | ₹1.43B |
| Enterprise Value | ₹1.25B | ₹1.30B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.38 | 3.61 |
| Enterprise to EBITDA | -30.61 | 33.75 |
| Risk & Other Metrics | ||
| Beta | 0.54 | -0.19 |
| Book Value per Share (MRQ) | ₹29.26 | ₹19.71 |
Financial Statements Comparison: Banka Bioloo vs Secmark Consultancy
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BANKA | SECMARK |
|---|---|---|
| Revenue/Sales | ₹111.41M | ₹124.99M |
| Cost of Goods Sold | ₹26.57M | ₹18.64M |
| Gross Profit | ₹84.84M | ₹106.34M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-2.96M | ₹50.80M |
| EBITDA | ₹14.07M | ₹63.16M |
| Pre-Tax Income | ₹-1.25M | ₹52.48M |
| Income Tax | ₹-1.27M | ₹13.14M |
| Net Income (Profit) | ₹21,000 | ₹39.35M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BANKA | SECMARK |
|---|---|---|
| Cash & Equivalents | ₹2.45M | ₹238,000 |
| Total Current Assets | ₹532.42M | ₹211.59M |
| Total Current Liabilities | ₹378.94M | ₹128.87M |
| Long-Term Debt | ₹116.71M | ₹0 |
| Total Shareholders Equity | ₹315.85M | ₹205.11M |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹157.66M | ₹16.03M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BANKA | SECMARK |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BANKA | SECMARK |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 11,461 | 1,821 |
| Average Daily Volume (90 Day) | 21,277 | 2,033 |
| Shares Outstanding | 10.87M | 10.41M |
| Float Shares | 4.55M | 2.22M |
| % Held by Insiders | N/A | 0.84% |
| % Held by Institutions | N/A | 0.00% |
Dividend Analysis & Yield Comparison: Banka Bioloo vs Secmark Consultancy
| Metric | BANKA | SECMARK |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |